Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
Yongde Peng, Jiaqing Dou, Qing Su, Zhufang Tian et al.
Citations
1 citations
Journal
Drug Design Development and Therapy
Topics
Diabetes Treatment and Management
Field-Weighted Citation Impact (FWCI)
1.29
article
Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes
Yongde Peng, Jiaqing Dou, Qing Su, Zhufang Tian, Jiao Sun, Min Zhang, Bo Feng, Xuemei Yu, Xiaohua Li, Hongyan Deng, Jianxia Shi, Yi Lin, Suo Lixia
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Drug Design Development and TherapyVol. Volume 19
Institutions
Tongji University (CN), Shanghai Jiao Tong University (CN), Fudan University (CN), XinHua Hospital (CN), Jiading District Central Hospital (CN), Xian Central Hospital (CN), Wuhan Puai Hospital (CN), Shanghai University of Traditional Chinese Medicine (CN), Huadong Hospital (CN), Chaohu Hospital of Anhui Medical University (CN), Zhongshan Hospital (CN), Shanghai First People's Hospital (CN)
Ask Laika to Summarize, Analyze, and Connect papers live on the map.
Summarize Papers & Methodologies
Extract key findings, datasets, and comparative methods across publications.
Benchmark Rankings & Visual Analytics
Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.
Connect Distant Disciplines
Bridge topological clusters on the map to find hidden collaborative intersections.
Enhancing Diabetes Treatment: Comparing Pioglitazone/Metformin with Dapagliflozin Versus Basal Insulin/Metformin in Type 2 Diabetes — Yongde Peng, Jiaqing Dou, et al. · Drug Design Development and Therapy (2025) | TGRS Research Map | TGRS